Advertisement
Screener

AMICUS THERAPEUTICS, INC. Operating Lease, Expense

AMICUS THERAPEUTICS, INC. Operating Lease, Expense

AMICUS THERAPEUTICS, INC. reported Operating Lease, Expense of $9.50 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.

Discontinued › Expense Statement › Operating Expenses

us-gaap:OperatingLeaseExpense · last filed 2024-02-28

  • AMICUS THERAPEUTICS, INC. operating lease, expense for the quarter ending 2019-12-31 was $3.00M.
  • AMICUS THERAPEUTICS, INC. operating lease, expense for the quarter ending 2019-09-30 was $3.00M.
  • AMICUS THERAPEUTICS, INC. operating lease, expense for the quarter ending 2019-06-30 was $2.70M.
  • AMICUS THERAPEUTICS, INC. operating lease, expense for the quarter ending 2019-03-31 was $2.10M.
  • AMICUS THERAPEUTICS, INC. operating lease, expense for fiscal 2023 was $9.50M, a 3.06% decline from fiscal 2022.
  • AMICUS THERAPEUTICS, INC. operating lease, expense for fiscal 2022 was $9.80M, a 2.00% decline from fiscal 2021.
  • AMICUS THERAPEUTICS, INC. operating lease, expense for fiscal 2021 was $10.00M, a 9.91% decline from fiscal 2020.
  • AMICUS THERAPEUTICS, INC. operating lease, expense for fiscal 2020 was $11.10M, a 2.78% increase from fiscal 2019.
Period endOperating Lease, Expense 3 monthOperating Lease, Expense 6 monthOperating Lease, Expense 9 monthOperating Lease, Expense 12 month
2023-12-31$9.50M
10-K · filed 2024-02-28
2022-12-31$9.80M
10-K · filed 2024-02-28
2021-12-31$10.00M
10-K · filed 2023-03-01
2020-12-31$11.10M
10-K · filed 2022-02-24
2019-12-31$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$6.00M
derived: sum of 2 quarters · filed 2021-03-01
$8.70M
derived: sum of 3 quarters · filed 2021-03-01
$10.80M
10-K · filed 2021-03-01
2019-09-30$3.00M
10-Q · filed 2019-11-12
$5.70M
derived: sum of 2 quarters · filed 2019-11-12
$7.80M
10-Q · filed 2019-11-12
2019-06-30$2.70M
10-Q · filed 2019-08-08
$4.80M
10-Q · filed 2019-08-08
2019-03-31$2.10M
10-Q · filed 2019-05-09